Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX versus placebo for adult masseter muscle prominence
NL-OMON60207Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Oct 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in masseter hypertrophy comparing BOTOX with Placebo (2 arms). Primary endpoints: Investigator-assessed MMPS response at Day 90 and Subject-assessed MMPS-P response at Day 90. Started Oct 2023; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
masseter hypertrophy
Beyond the preview
Go deeper on NL-OMON60207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60207.